Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover · Investor's Business Daily

In This Article:

IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.